Research Article

Assessment of Left Ventricular Structural Remodelling in Patients with Diabetic Cardiomyopathy by Cardiovascular Magnetic Resonance

Table 1

Demographic characteristics.

DCM ()Control () value

Anthropometry
 Age, y53.8 ± 8.851.9 ± 13.60.533
 Diabetic history, y5.9 ± 3.9
 Male, %52.045.20.611
 Height, m1.62 ± 0.071.61 ± 0.070.634
 Weight, kg63.8 ± 11.661.0 ± 10.50.336
 BMI, kg/m224.1 ± 2.923.4 ± 3.10.362
 BSA, m21.68 ± 0.181.65 ± 0.170.457
 Systolic blood pressure, mmHg122.2 ± 10.0119.3 ± 11.50.324
 Diastolic blood pressure, mmHg81.6 ± 6.483.5 ± 7.70.333

Biochemical exam
 Urine microalbumin, mg/dL0.3 [0.1–5.0]1.2 [0.6–1.8]0.177
 Blood urea nitrogen, mmol/L5.8 [4.8–7.0]6.0 [5.1–6.9]0.716
 Creatinine, umol/L68.7 ± 21.964.1 ± 16.90.381
 Cystatin C, mg/L0.77 [0.66–0.88]0.75 [0.64–0.86]0.594
 AST, 22.0 [17.8–29.5]29.5 [23.2–35.4]0.008
 LDH, IU/L201.0 ± 45.3197.7 ± 46.50.809
α-HBDH, IU/L128.4 ± 31.6131.2 ± 38.70.799
 CK, IU/L97.4 [69.9–123.5]86.0 [65.4–108.4]0.421
 Ischemia modified albumin, U/mL81.9 ± 7.573.6 ± 5.90.001
 Total cholesterol, mmol/L5.7 [4.8–6.9]5.3 [4.9–6.0]0.205
 Triglycerides, mmol/L2.4 [1.5–4.3]1.3 [0.9–2.0]0.004
 HDL, mmol/L1.2 [1.0–1.4]1.4 [1.1–1.7]0.026
 LDL, mmol/L3.5 [2.8–4.3]3.3 [3.1–3.7]0.703
 Glucose, mmol/L8.6 [7.2–11.1]5.3 [4.9–5.8]0.000
 Glycated hemoglobin, %6.9 [6.3–9.1]5.6 [5.4–5.8]0.000
 Troponin, 10−3 ug/L8 [5–12]5 [3–6]0.003
 Myoglobin, ng/mL27.6 [22.3–49.4]30.5 [22.4–38.5]0.739
 Insulin, uIU/mL16.4 ± 7.012.1 ± 4.30.022
 C peptide, ng/mL 1.7 [1.2–2.3]1.1 [0.8–1.4]0.007

Echocardiography
 Doppler mitral annular velocity 0.80 ± 0.09